Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
1.060
-0.020 (-1.85%)
Feb 21, 2025, 4:00 PM EST - Market closed
Hoth Therapeutics Employees
As of December 31, 2023, Hoth Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,502,526
Market Cap
7.32M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
HOTH News
- 12 days ago - Hoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer Therapeutic - PRNewsWire
- 4 weeks ago - Hoth Therapeutics Regains Compliance with Nasdaq Listing Requirements - PRNewsWire
- 4 weeks ago - Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications - PRNewsWire
- 5 weeks ago - Hoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025 - PRNewsWire
- 6 weeks ago - Hoth Therapeutics Responds to Market Rumors and Shareholder Inquiries - PRNewsWire
- 6 weeks ago - Why Is Hoth Therapeutics Stock Flying Higher On Tuesday? - Benzinga
- 6 weeks ago - Hoth Therapeutics Achieves Breakthrough in Phase 2a Trial: HT-001 Delivers 100% Success in Combating Cancer Treatment Skin Toxicities - PRNewsWire
- 2 months ago - Hoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity Treatment - PRNewsWire